Antiviral Activity of the Polyene Macrolide Roseofungin Against Influenza a Virus: In Vitro, In Ovo, and Preliminary In Vivo Evaluation
Authors:
- Andrey BogoyavlenskiyABAndrey Bogoyavlenskiy
- Vladimir BerezinVBVladimir Berezin
- Pavel AlexyukPavel Alexyuk
- Madina AlexyukMAMadina Alexyuk
- Irina ZaitsevaIZIrina Zaitseva
- Aidar MukhametkaliyevAidar Mukhametkaliyev
- Yergali MoldakhanovYMYergali Moldakhanov
- Elmira AnarkulovaEAElmira Anarkulova
- Timur KerimovTKTimur Kerimov
- Vyacheslav DushenkovVDVyacheslav Dushenkov
Open Access
Abstract
Roseofungin, a polyene macrolide antibiotic produced by Streptomyces roseoflavus, was evaluated for antiviral activity against Influenza A virus using complementary in vitro, in ovo, and preliminary in vivo toxicity models, supported by molecular docking and molecular dynamics simulations. The compound exhibited antiviral activity against multiple influenza A virus subtypes, including an oseltamivir-resistant H1N1 strain, with EC50 values ranging from 2.0 to 2.5 μg/mL and selectivity indices of 20–25. Functional assays demonstrated that roseofungin interfered with early stages of the viral life cycle by reducing viral adsorption and partially inhibiting neuraminidase activity. In virucidal assays, treatment with roseofungin resulted in a 1.5–2.5 log10 reduction in infectious viral titers. Acute toxicity studies in mice indicated low toxicity under the experimental conditions (LD50 > 25 mg/kg). Molecular docking predicted favorable interactions of roseofungin with multiple influenza A virus proteins. Subsequent molecular dynamics simulations of the hemagglutinin–roseofungin complex maintained the stability of the predicted binding mode across three independent 50 ns simulations (150 ns cumulative). Collectively, these findings demonstrate that roseofungin possesses broad-spectrum antiviral activity against genetically diverse Influenza A virus strains and represents a promising lead compound for the development of novel membrane-active antiviral agents. Further studies are warranted to elucidate its molecular mechanism of action and to evaluate its therapeutic potential in vivo.Keywords
Funding Information
- Ministry of Science and Higher Education of the Republic of Kazakhstan (AP23488108)
This publication has 37 references indexed in Scilit:
- A critical review of the mechanisms of virus removal by membrane bioreactors–Influencing factors and correlation with operating parametersJournal of Environmental Management, 2025
- Antiviral activity of the water extract and ethanol extract of Sorbus commixta against influenza A virus in vitroHeliyon, 2024
- Influenza: epidemiology and hospital managementMedicine, 2021
- Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects2017
- Influenza Virus Titration, Antigenic Characterization, and Serological Methods for Antibody Detection2012
- In vivo evaluation of the antiviral activity of Cajanus cajan on measles virusArchives of Virology, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Attachment of viruses to cell receptors and penetration of viruses into cells1983